About Carcinotech
Carcinotech is a company based in Edinburgh (United Kingdom) founded in 2018. It operates as a B2B. Carcinotech has raised $7.35 million across 4 funding rounds from investors including Santander UK, Scottish Enterprise and Maven Capital Partners. The company has 1 employees as of June 30, 2021. Carcinotech offers products and services including Biopsy Sourcing, 3D Tumor Development, and Oncology Assays. Carcinotech operates in a competitive market with competitors including Biocytogen, Applied StemCell, GenOway, Newcells Biotech and Interius Biotherapeutics, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 1 as on 30 Jun, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Carcinotech Ltd
- Date of Incorporation 31 Jul, 2018
- Jurisdiction EDINBURGH, MIDLOTHIAN, SCOTLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.35 M (USD)
in 4 rounds
-
Latest Funding Round
$5.3 M (USD), Seed
Jan 29, 2024
-
Investors
Santander UK
& 11 more
-
Employee Count
1
as on Jun 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Carcinotech
Carcinotech offers a comprehensive portfolio of products and services, including Biopsy Sourcing, 3D Tumor Development, and Oncology Assays.
Sourcing tumor biopsies for oncology research and development.
Creating 3D-printed tumor models for drug testing applications.
Conducting assays to evaluate cancer treatments and therapies.
People of Carcinotech
Unlock access to complete
Funding Insights of Carcinotech
Carcinotech has successfully raised a total of $7.35M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $5.3 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Carcinotech
Carcinotech has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Santander UK, Scottish Enterprise and Maven Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in science and technology is managed by Eos.
|
Locked | Locked | Locked | |
|
Early-stage investment is provided to promising Scottish entrepreneurs.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on social impact companies
|
Locked | Locked | Locked |
Investor details for Carcinotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Carcinotech
Investment portfolio details for Carcinotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Carcinotech
Detailed financials for Carcinotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Carcinotech Comparisons
Peer comparison for Carcinotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Carcinotech
Carcinotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, GenOway, Newcells Biotech and Interius Biotherapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Cell-based assays and 3D microtissues for drug screening are developed.
|
Detailed competitors of Carcinotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carcinotech
Complete news archive for Carcinotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carcinotech
Carcinotech was founded in 2018.
Carcinotech is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Carcinotech is a funded company, having raised a total of $7.35M across 4 funding rounds to date.
As of Jun 30, 2021, the latest employee count at Carcinotech is 1.
Carcinotech specializes in preclinical oncology services, utilizing 3D-bioprinted, patient-derived tumors to advance drug development and personalized treatments. They offer biopsy sourcing, tumor development, and oncology assays to support early drug discovery and testing. Based in the United Kingdom, they collaborate with biotech organizations and researchers to enhance cancer research efficiency and accuracy.
Carcinotech's top competitors include Biocytogen, Applied StemCell and Newcells Biotech.
Carcinotech offers Biopsy Sourcing, 3D Tumor Development, and Oncology Assays.
Carcinotech has 12 investors. Key investors include Santander UK, Scottish Enterprise, Maven Capital Partners, The University of Edinburgh, and Eos.